Boon san Teoh | Antimicrobial Resistance | Best Researcher Award

Ms. Boon san Teoh | Antimicrobial Resistance | Best Researcher Award 

Senior pharmacist | Singapore General Hospital | Singapore

Dr. Boon San Teoh is a distinguished clinician and researcher affiliated with Singapore General Hospital, Singapore’s leading medical institution recognized for excellence in clinical research and healthcare innovation. His professional expertise lies in infectious diseases and antimicrobial therapy, with a particular research interest in the clinical application and comparative effectiveness of advanced antibiotics such as daptomycin and linezolid in complex hospital settings. Dr. Teoh’s recent publication, “A Retrospective Study on the Use of Daptomycin and Linezolid in Singapore General Hospital,” featured in the journal Antibiotics (2025), reflects his commitment to improving patient outcomes through evidence-based medical practice and antimicrobial stewardship. His research contributions emphasize optimizing therapeutic interventions to address antibiotic resistance and ensure safer, more effective care. Beyond his scholarly endeavors, Dr. Teoh actively collaborates with multidisciplinary teams across microbiology, pharmacology, and hospital medicine, promoting integrated approaches to clinical challenges in infectious disease management. Through his engagement in research, mentorship, and collaborative healthcare improvement initiatives, Dr. Teoh contributes significantly to the advancement of medical science in Singapore and beyond. His academic integrity, clinical insight, and dedication to patient-centered research position him as a valuable contributor to global medical innovation, enhancing understanding of infectious disease dynamics and shaping strategies for better health outcomes worldwide.

Profiles: ORCID

Featured Publication

1. Teoh, B. S., Liew, Y. X., Wang, Y., Chung, S. J., & Tan, B. H. (2025, October 28). A retrospective study on the use of Daptomycin and Linezolid in Singapore General Hospital. Antibiotics, 14(11), 1088

Dr. Boon San Teoh’s research advances antimicrobial stewardship and patient safety through evidence-based evaluation of antibiotic therapies. His work at Singapore General Hospital contributes to optimizing clinical outcomes, reducing antimicrobial resistance, and strengthening global efforts toward sustainable healthcare innovation.

Hans Rudolf Pfaendler | Microbiology | Best Researcher Award

Prof. Dr. Hans Rudolf Pfaendler | Microbiology | Best Researcher Award 

Professor Emeritus | University of Munich | Germany

Prof. Dr. Hans Rudolf Pfaendler is a distinguished researcher and faculty member at Ludwig-Maximilians-Universität München, Germany, with a focus on microbiology and chemical sciences. Over his career, he has authored 35 publications that have collectively garnered 660 citations, reflecting both the quality and impact of his work. His research spans innovative methodologies in microbiology, including the development of the CarbaLux test for detecting carbapenemases and AmpC beta-lactamases, as well as contributions to organic chemistry, such as novel formaldehyde derivatives and vicinal diamination of terminal olefins. Pfaendler has collaborated with a broad network of 46 co-authors, highlighting his commitment to interdisciplinary and international research initiatives. His work has significantly advanced diagnostic techniques and synthetic chemistry, providing tools that are not only academically influential but also societally relevant, particularly in addressing antimicrobial resistance and chemical synthesis challenges. Recognized for both methodological innovation and practical applications, his scholarship bridges fundamental research and translational impact, underlining his standing as a leading figure in his field.

Profiles: Scopus | ORCID

Featured Publications

1. Pfaendler, H. R. (1994). ß-Lactame – ein aktueller Überblick: The Organic Chemistry of β-Lactams. Von G. I. Georg. VCH, Weinheim 1993. 381 S., 39 Abb., 68 Tab., geb., DM 189,-. ISBN 3-527-28188-6. Nachrichten aus Chemie, Technik und Laboratorium, 42(1), 29–30.Pf.

2. Pfaendler, H. R., Hendel, W., & Nagel, U. (1992). Stable Oxapenem-3-Carboxylic Acids – A New Class of β-Lactam Antibiotics. Influence of 2- and 6-Alkyl Substituents. Zeitschrift für Naturforschung B, 47(7–8), 726–732

3. Pfaendler, H., Hartung, R., Golz, G., Schlaf, S., Silvennoinen, G., Polborn, K., & Mayer, P. (2009). A Simple and Efficient Preparation of Novel Formaldehyde Derivatives. Synthesis, 2009(1), 9–16.

4. Pfaendler, H. R. (1990). Robinsonade: „Robert Robinson ‐ Chemist Extraordinary”. Von Trevor I. Williams. Oxford University Press (Clarendon Press Oxford) 1990. 201 S., 13 Fotos, geb. $ 25.00, ISBN 0‐19‐858180‐7. Nachrichten aus Chemie, Technik und Laboratorium, 38(10), 318–319.

5. Pfaendler, H. R., Weishaupt, R., & Meffert, H. (2000). Synthesis and Biological Activities of an α-Methyl and a β-Methyl Carbapenem and the Corresponding Unsubstituted Compound. Bioorganic & Medicinal Chemistry Letters, 10(12), 1417–1420.

Prof. Dr. Hans Rudolf Pfaendler’s work advances the rapid detection and characterization of antimicrobial resistance through innovative diagnostic tools, such as the CarbaLux test for carbapenemases and AmpC beta-lactamases. By enabling faster, more accurate identification of resistant bacterial strains, his research supports improved clinical decision-making, enhances patient outcomes, and informs global strategies to combat antibiotic resistance. This contribution bridges fundamental microbiology with practical healthcare applications, promoting both scientific understanding and societal impact.

Mahfuza Nasrin | Microbiology | Best Researcher Award

Assoc. Prof. Dr. Mahfuza Nasrin | Microbiology | Best Researcher Award 

Associate Professor | Uttara Adhunik Medical College | Bangladesh

Mahfuza Nasrin is an Associate Professor specializing in antimicrobial resistance and antimicrobial stewardship, with a strong focus on clinical microbiology and infection control. Her research portfolio encompasses the bacteriological profiling of bloodstream, wound, and urinary tract infections, as well as the characterization of antimicrobial susceptibility patterns in Bangladesh. She has contributed to over ten peer-reviewed publications, which have collectively garnered 16 citations, reflecting her growing impact in the field. Nasrin has collaborated with national and international colleagues on studies that map antimicrobial resistance trends across diverse clinical settings, highlighting variations between low-, middle-, and high-income regions and offering critical insights for global public health strategies. Her recent work emphasizes the emerging threat of carbapenem-resistant Enterobacterales and the importance of establishing effective infection prevention and control protocols in tertiary care hospitals. Beyond her research, Nasrin’s contributions advance antimicrobial stewardship and inform clinical decision-making, with tangible societal impact in improving patient outcomes and guiding evidence-based policy in healthcare institutions. She continues to engage in collaborative studies and preprints, demonstrating a commitment to innovation, knowledge dissemination, and the global fight against antimicrobial resistance.

Profiles: Scopus | Google Scholar | ORCID

Featured Publications

1. Nasrin, M., Begum, M. F., Rahman, F., Karim, R., Bhuiyan, M. M., & Nawal, N. (2025). Antibiogram and antimicrobial susceptibility pattern of bacterial isolates from a tertiary care hospital in Dhaka. Archives of Microbiology & Immunology, 9(1), 31–37. Cited: 1

2. Nawal, D. N., Begum, M. F., Nasrin, M., Rahman, F., Karim, R., Alam, M. S., … & Alam, D. M. S. (2025). Bacteriological profile and antibiotic susceptibility pattern of clinical isolates from a tertiary care hospital in Dhaka, Bangladesh. Fortune Journal of Health Sciences, 8, 668–674. Cited: 1

3. Nasrin, M., Begum, F., Sujan, M. J., Barua, H. T., Habib, Z. H., Rizvi, S. M. S., … (2025). Bacterial profile and antimicrobial resistance pattern from different clinical specimens at Uttara Adhunik Medical College Hospital, Dhaka. Preprints. Cited: 1

4. Nasrin, M., Begum, M. F., Karim, R., Alam, M. S., & Rahman, F. (2021). Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among bloodstream infection suspected patients attending in a referral hospital. Bangladesh Journal of Medical Microbiology, 15(2), 5–11. Cited: 6

5. Begum, M. F., Nasrin, M., & Alam, M. S. (2020). Bacteriological profile and antibiotic susceptibility patterns of wound infections at Uttara Adhunik Medical College Hospital, Dhaka. Bangladesh Journal of Medical Microbiology, 14(1), 15–19. Cited: 5

Dr. Mahfuza Nasrin’s work on antimicrobial resistance and bacterial infection profiling advances understanding of pathogen susceptibility patterns in clinical settings, directly informing antibiotic stewardship and public health strategies in Bangladesh and globally. Her research supports evidence-based interventions to combat drug-resistant infections, improving patient outcomes and guiding policy in infectious disease management.

Marie Amougou Atsama | Gastroenteritis | Best Researcher Award

Dr. Marie Amougou Atsama | Gastroenteritis | Best Researcher Award 

Research Officer at Research Center on Emerging and Re-merging ,Cameroon

Dr. Amougou Atsama Marie is a highly accomplished public health manager and virologist with extensive expertise in research, biosafety, and disease prevention. She currently serves as Biosafety Officer and Public Health Manager at the Research Center for Emerging and Re-Emerging Infectious Diseases in Yaoundé, Cameroon. With a strong focus on viral hepatitis and other infectious diseases, she has led numerous initiatives aimed at prevention, surveillance, and control within Central Africa. Her work spans laboratory research, public health program coordination, and stakeholder engagement at national and regional levels. Dr. Marie has played a key role in developing diagnostic protocols, improving health systems, and fostering community-based prevention strategies. Her leadership extends to advocacy, capacity building, and integrating innovative approaches, such as the use of improved traditional medicine in disease management. Dedicated, results-oriented, and deeply committed to public health, she continues to advance impactful research and healthcare improvement in underserved communities.

Professional Profile

Scopus

Education

Dr. Amougou Atsama Marie possesses a strong academic background in virology, biotechnology, and biochemistry, built through rigorous studies and advanced research training. She completed her doctoral and postdoctoral work at the renowned Centre Pasteur of Cameroon, where she specialized in the molecular and epidemiological aspects of various viral pathogens. She earned her master’s degree in biotechnology and development from the University of Yaoundé I, developing a foundation in molecular biology, diagnostics, and public health applications. Her undergraduate degree in biochemistry further strengthened her understanding of biological systems and analytical methods. Over the years, she has complemented her formal education with specialized certifications in good clinical laboratory practice, human research ethics, quality control management, and advanced genomic sequencing techniques. These academic achievements, coupled with hands-on research experience, have equipped her with both theoretical knowledge and practical expertise, enabling her to design, implement, and oversee complex public health and laboratory research programs effectively.

Experience

Dr. Amougou Atsama Marie has established herself as a leader in public health management and virology through diverse roles in research, biosafety, and quality control. As Biosafety and Research Officer, she has coordinated regional efforts for the elimination of viral hepatitis B and C across multiple Central African countries, facilitating capacity-building workshops and advocacy programs. She has developed and optimized diagnostic protocols for a range of viruses, including hepatitis B, C, D, E, Dengue, Chikungunya, and Zika, while implementing robust surveillance and monitoring systems. Her work involves close collaboration with national and international health partners to strengthen healthcare delivery and integrate innovative solutions into disease prevention strategies. She has also led research on vaccine response, genetic diversity of hepatitis viruses, and the integration of traditional medicine in treatment. In addition to her technical expertise, she actively engages in community education, raising awareness about infectious disease prevention among students and the public.

Awards and Honors

Dr. Amougou Atsama Marie has received multiple recognitions for her outstanding contributions to virology research, biosafety, and public health initiatives. Her leadership in hepatitis elimination programs across Central Africa has earned her commendations from national health authorities and regional stakeholders. She has been honored for her innovative approaches in integrating traditional medicine into viral hepatitis management and for developing advanced diagnostic protocols for various infectious diseases. Her work in facilitating high-impact workshops, mentoring healthcare professionals, and contributing to national health guidelines has been acknowledged by both academic and public health institutions. She is respected for her role in promoting cross-border collaboration in disease control and for her dedication to building local capacity in laboratory diagnostics and biosafety management. Through these recognitions, Dr. Marie’s influence extends beyond research, highlighting her as a key figure in advancing evidence-based, community-centered health solutions in Cameroon and the broader Central African region.

Research Focus

Dr. Amougou Atsama Marie’s research centers on the prevention, diagnosis, and control of viral hepatitis and other emerging infectious diseases. She is particularly focused on understanding the genetic diversity of hepatitis viruses and its impact on vaccine response and treatment outcomes. Her work involves developing and optimizing molecular and serological diagnostic protocols for a wide range of viruses, including arboviruses such as Dengue, Chikungunya, and Zika. She also investigates strategies to integrate traditional medicine into viral hepatitis management, aiming to improve accessibility and cultural acceptance of treatment in local communities. Dr. Marie is actively involved in operational research that strengthens health systems, enhances biosafety measures, and improves outbreak preparedness. Her approach combines laboratory-based research with community engagement, ensuring that scientific advancements translate into practical, sustainable health solutions. By bridging research, policy, and public health action, she contributes to regional and global efforts to control infectious diseases effectively.

Publication Top Notes

Title: First molecular detection of five gastroenteritis viruses in untreated wastewater and impact of seasonal change on their distribution in Cameroon
Journal: One Health (2025)
Summary:
This study presents the first molecular evidence of five major gastroenteritis-causing viruses detected in untreated wastewater in Cameroon. Using molecular techniques, researchers identified the presence of these pathogens and assessed how their distribution varies across different seasons. The findings reveal a clear influence of seasonal patterns on virus prevalence, highlighting the importance of wastewater surveillance as an early warning system for community health risks. The research supports the One Health approach by linking environmental monitoring to public health interventions, offering valuable insights for disease prevention and control strategies in the region.

Conclusion

Dr. Amougou Atsama Marie embodies a rare combination of scientific expertise, leadership, and dedication to public health improvement. Her career reflects a consistent commitment to advancing research, enhancing diagnostic capabilities, and promoting evidence-based interventions for infectious disease control. Through her work in laboratory innovation, biosafety, and community engagement, she has significantly contributed to the fight against viral hepatitis and other infectious threats in Central Africa. Her ability to collaborate with diverse stakeholders, from policymakers to grassroots organizations, underscores her holistic approach to healthcare solutions. By integrating modern scientific methods with culturally sensitive strategies, she ensures that her work is both impactful and sustainable. Dr. Marie’s professional journey serves as an inspiring example of how research excellence and public health service can intersect to create lasting change, improving the lives of individuals and strengthening health systems across regions.